Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

UNLABELLED: Cardiovascular magnetic resonance (CMR) stress T1 mapping using adenosine and regadenoson can differentiate ischemic, infarcted, and healthy myocardium. However, the effect of dipyridamole remains unclear. This study evaluates whether dipyridamole-induced stress T1-mapping can distinguish myocardial tissue types. Twenty-five healthy controls and 20 patients with coronary artery disease (CAD) underwent rest and dipyridamole stress T1-mapping (ShMOLLI), followed by gadolinium-based quantitative perfusion imaging at 1.5T. Native T1 values and stress T1 reactivity (dT1) were assessed across different myocardial tissues. Correlations between dT1 and myocardial blood flow (MBF) were examined. In healthy controls, global rest T1 was 934 ± 26ms, with a stress-induced increase of 6.5 ± 0.6% (p < 0.0001). Infarcted myocardium showed elevated resting T1 (1146 ± 71 ms) with an absent stress response (dT1 = -0.9%±1.8%). Ischemic myocardium had mildly elevated rest T1 (965 ± 26 ms; p < 0.001) and blunted reactivity (dT1 = 1.3 ± 0.6%) compared to healthy myocardium. Remote myocardium had rest T1 similar to normal tissue (936 ± 19 ms; p > 0.05) but reduced stress reactivity (dT1 = 4.5 ± 1.1%; p < 0.0001) compared to norm. dT1 strongly correlated with stress MBF (r = 0.80) and myocardial perfusion reserve (r = 0.70) (both p < 0.0001). Dipyridamole-induced stress T1-mapping can differentiate infarcted, ischemic, and healthy myocardium, supporting its use in non-contrast CMR for myocardial tissue characterization. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1038/s41598-026-40946-0.

More information Original publication

DOI

10.1038/s41598-026-40946-0

Type

Journal article

Publication Date

2026-02-24T00:00:00+00:00

Volume

16

Keywords

Cardiovascular magnetic resonance, Dipyridamole, ShMOLLI, T1 mapping